These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6140632)

  • 1. Neuroleptic classification: implications for tardive dyskinesia.
    Hyttel J; Christensen AV; Arnt J
    Mod Probl Pharmacopsychiatry; 1983; 21():49-64. PubMed ID: 6140632
    [No Abstract]   [Full Text] [Related]  

  • 2. Classification of neuroleptics: implications for tardive dyskinesia.
    Christensen AV
    Pol J Pharmacol Pharm; 1985; 37(3):295-309. PubMed ID: 2866499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Animal models of tardive dyskinesia: their use in the search for new treatment methods.
    Goetz CG; Klawans HL; Carvey P
    Mod Probl Pharmacopsychiatry; 1983; 21():5-20. PubMed ID: 6140633
    [No Abstract]   [Full Text] [Related]  

  • 4. The pathophysiology of tardive dyskinesia.
    Klawans HL; Carvey P; Tanner CM; Goetz CG
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):38-41. PubMed ID: 2858479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenytoin potentiation of neuroleptic-induced dyskinesias.
    Sethi KD; Hitri A; Diamond BI
    Mov Disord; 1990; 5(4):325-7. PubMed ID: 2147979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Choline chloride in animal models of tardive dyskinesia.
    Davis KL; Hollister LE; Vento AL; Simonton S
    Life Sci; 1978 May; 22(19):1699-707. PubMed ID: 566830
    [No Abstract]   [Full Text] [Related]  

  • 7. Type I tardive dyskinesia induced by anticholinergic drugs, dopamine agonists and neuroleptics.
    Chouinard G; Steinberg S
    Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(4-6):571-8. PubMed ID: 6131490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine receptor function and spontaneous orofacial dyskinesia in rats during 6-month neuroleptic treatments.
    Waddington JL; Cross AJ; Gamble SJ; Bourne RC
    Adv Biochem Psychopharmacol; 1983; 37():299-308. PubMed ID: 6138952
    [No Abstract]   [Full Text] [Related]  

  • 9. The pathophysiology of extrapyramidal side-effects of neuroleptic drugs.
    Marsden CD; Jenner P
    Psychol Med; 1980 Feb; 10(1):55-72. PubMed ID: 6104342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Managing tardive dyskinesia.
    Casey DE
    J Clin Psychiatry; 1978 Oct; 39(10):748-53. PubMed ID: 30759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine receptor sensitivity changes with chronic stimulants.
    Lee TH; Ellinwood EH; Nishita JK
    Ann N Y Acad Sci; 1988; 537():324-9. PubMed ID: 3059930
    [No Abstract]   [Full Text] [Related]  

  • 12. MK-771 antagonizes the enhanced response to apomorphine in rats treated chronically with haloperidol - implications for tardive dyskinesia.
    Yarbrough GG; Faison EP; Antolik EK
    Neurosci Lett; 1982 Dec; 34(3):321-3. PubMed ID: 6819493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Tardive dyskinesia: problems of pathogenesis, treatment and prevention].
    Olajossy M
    Psychiatr Pol; 1980; 14(6):621-5. PubMed ID: 6112766
    [No Abstract]   [Full Text] [Related]  

  • 14. Neuroleptic plasma levels and tardive dyskinesia.
    Giller E
    Schizophr Bull; 1980; 6(3):391-2. PubMed ID: 6105706
    [No Abstract]   [Full Text] [Related]  

  • 15. Tardive dyskinesia: review and update.
    Klawans HL; Goetz CG; Perlik S
    Am J Psychiatry; 1980 Aug; 137(8):900-8. PubMed ID: 6106395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug therapy of tardive dyskinesia.
    Kobayashi RM
    N Engl J Med; 1977 Feb; 296(5):257-60. PubMed ID: 12469
    [No Abstract]   [Full Text] [Related]  

  • 17. Tardive dyskinesia: clinical, biological, and pharmacological perspectives.
    Berger PA; Rexroth K
    Schizophr Bull; 1980; 6(1):102-16. PubMed ID: 6102788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticholinergics promote neuroleptic-induced tardive dyskinesia.
    Borison RL; Diamond BI
    Adv Biochem Psychopharmacol; 1980; 24():359-61. PubMed ID: 6105786
    [No Abstract]   [Full Text] [Related]  

  • 19. Movement disorders in patients with coexistent neuroleptic-induced tremor and tardive dyskinesia: EMG and pharmacological study.
    Rondot P; Bathien N
    Adv Neurol; 1987; 45():361-6. PubMed ID: 2881446
    [No Abstract]   [Full Text] [Related]  

  • 20. Induction of tardive dyskinesia in Cebus apella and Macaca speciosa monkeys: a review.
    Domino EF
    Psychopharmacology Suppl; 1985; 2():217-23. PubMed ID: 2860660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.